Cat. No.: DIA-0230027
Product Information | |
---|---|
CAS No. | 413599-62-9 |
Formula | C19H16BrFN6O2 |
Molecular Weight | 459.27 |
SMILES | COC1=CC2=C(NC3=CC=C(Br)C=C3F)N=CN=C2C=C1OCC[N]4C=CN=N4 |
Target | VEGF RTK |
Product Description | ZD-4190 is a submicromolar inhibitor of VEGF RTK activity in vitro with IC50 values of 29 ± 4 nM and 708 ± 63 nM for KDR and Flt-1, respectively. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.